185 related articles for article (PubMed ID: 17979789)
1. Development of radioligands for imaging of brain norepinephrine transporters in vivo with positron emission tomography.
Schou M; Pike VW; Halldin C
Curr Top Med Chem; 2007; 7(18):1806-16. PubMed ID: 17979789
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of norepinephrine transporters.
Ding YS; Lin KS; Logan J
Curr Pharm Des; 2006; 12(30):3831-45. PubMed ID: 17073682
[TBL] [Abstract][Full Text] [Related]
3. Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomography.
Comley RA; Salinas CA; Slifstein M; Petrone M; Marzano C; Bennacef I; Shotbolt P; Van der Aart J; Neve M; Iavarone L; Gomeni R; Laruelle M; Gray FA; Gunn RN; Rabiner EA
J Pharmacol Exp Ther; 2013 Aug; 346(2):311-7. PubMed ID: 23685546
[TBL] [Abstract][Full Text] [Related]
4. Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor.
Smith JA; Bourdet DL; Daniels OT; Ding YS; Gallezot JD; Henry S; Kim KH; Kshirsagar S; Martin WJ; Obedencio GP; Stangeland E; Tsuruda PR; Williams W; Carson RE; Patil ST
Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522383
[TBL] [Abstract][Full Text] [Related]
5. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
6. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
[TBL] [Abstract][Full Text] [Related]
7. Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET.
Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Rujescu D; Kasper S; Lanzenberger R
Hum Brain Mapp; 2016 Mar; 37(3):884-95. PubMed ID: 26678348
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.
Schou M; Pike VW; Sóvágó J; Gulyás B; Gallagher PT; Dobson DR; Walter MW; Rudyk H; Farde L; Halldin C
Bioorg Med Chem; 2007 Jan; 15(2):616-25. PubMed ID: 17123820
[TBL] [Abstract][Full Text] [Related]
9. Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD.
Ding YS; Naganawa M; Gallezot JD; Nabulsi N; Lin SF; Ropchan J; Weinzimmer D; McCarthy TJ; Carson RE; Huang Y; Laruelle M
Neuroimage; 2014 Feb; 86():164-71. PubMed ID: 23933039
[TBL] [Abstract][Full Text] [Related]
10. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
Nogami T; Takano H; Arakawa R; Ichimiya T; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Takahata K; Suzuki M; Nagashima T; Mori T; Shimada H; Fukuda H; Sekine M; Tateno A; Takahashi H; Ito H; Okubo Y; Suhara T
Int J Neuropsychopharmacol; 2013 Jun; 16(5):937-43. PubMed ID: 23067569
[TBL] [Abstract][Full Text] [Related]
11. Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂.
Takano H; Arakawa R; Nogami T; Suzuki M; Nagashima T; Fujiwara H; Kimura Y; Kodaka F; Takahata K; Shimada H; Murakami Y; Tateno A; Yamada M; Ito H; Kawamura K; Zhang MR; Takahashi H; Kato M; Okubo Y; Suhara T
Int J Neuropsychopharmacol; 2014 Apr; 17(4):553-60. PubMed ID: 24345533
[TBL] [Abstract][Full Text] [Related]
12. PET Quantification of the Norepinephrine Transporter in Human Brain with (
Moriguchi S; Kimura Y; Ichise M; Arakawa R; Takano H; Seki C; Ikoma Y; Takahata K; Nagashima T; Yamada M; Mimura M; Suhara T
J Nucl Med; 2017 Jul; 58(7):1140-1145. PubMed ID: 27980046
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.
Plisson C; Stehouwer JS; Voll RJ; Howell L; Votaw JR; Owens MJ; Goodman MM
J Med Chem; 2007 Sep; 50(19):4553-60. PubMed ID: 17705359
[TBL] [Abstract][Full Text] [Related]
14. PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRT.
Ding YS; Singhal T; Planeta-Wilson B; Gallezot JD; Nabulsi N; Labaree D; Ropchan J; Henry S; Williams W; Carson RE; Neumeister A; Malison RT
Synapse; 2010 Jan; 64(1):30-8. PubMed ID: 19728366
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.
Stehouwer JS; Jarkas N; Zeng F; Voll RJ; Williams L; Camp VM; Malveaux EJ; Votaw JR; Howell L; Owens MJ; Goodman MM
J Med Chem; 2008 Dec; 51(24):7788-99. PubMed ID: 19053782
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
